Raloxifene News and Research

RSS
Raloxifene is an oral selective estrogen receptor modulator (SERM) that has oestrogenic actions on bone and anti-oestrogenic actions on the uterus and breast. It is used in the prevention of osteoporosis in postmenopausal women.
ACR’s updated guideline provides recommendations on treatment of glucocorticoid-induced osteoporosis

ACR’s updated guideline provides recommendations on treatment of glucocorticoid-induced osteoporosis

Bioinformatics helps identify new, untested drug combinations for treatment of breast cancer

Bioinformatics helps identify new, untested drug combinations for treatment of breast cancer

New guidelines recommend evaluation of osteoporosis risk for all postmenopausal women

New guidelines recommend evaluation of osteoporosis risk for all postmenopausal women

Omega-3 fatty acids can lower risk of breast cancer in postmenopausal obese women

Omega-3 fatty acids can lower risk of breast cancer in postmenopausal obese women

Estrogen may protect women against flu

Estrogen may protect women against flu

Aspirin does not improve survival among breast cancer patients with aggressive disease

Aspirin does not improve survival among breast cancer patients with aggressive disease

Estrogen-like drug may not be beneficial to women with Alzheimer's dementia

Estrogen-like drug may not be beneficial to women with Alzheimer's dementia

UT Southwestern announces launch of new health initiative

UT Southwestern announces launch of new health initiative

Researchers refine breast cancer risk model to give more accurate assessment

Researchers refine breast cancer risk model to give more accurate assessment

Raloxifene: FDA approved treatment for decreasing fracture risk in osteoporosis

Raloxifene: FDA approved treatment for decreasing fracture risk in osteoporosis

Research suggests effective role for natural steroid hormones in treating breast cancer

Research suggests effective role for natural steroid hormones in treating breast cancer

Experts join MD Anderson to end cancer

Experts join MD Anderson to end cancer

Chemoprevention and colon cancer: an interview with Dr. John Letterio, Case Western Reserve University School of Medicine

Chemoprevention and colon cancer: an interview with Dr. John Letterio, Case Western Reserve University School of Medicine

First Edition: January 10, 2014

First Edition: January 10, 2014

Anastrozole drug: An effective new option for breast cancer prevention for postmenopausal women

Anastrozole drug: An effective new option for breast cancer prevention for postmenopausal women

Genetic variations can identify women who are likely to benefit from breast cancer prevention drug

Genetic variations can identify women who are likely to benefit from breast cancer prevention drug

Gene variants may predict which women are most likely to benefit from breast cancer therapy

Gene variants may predict which women are most likely to benefit from breast cancer therapy

Genetic variations may help predict breast cancer risk in women who receive preventive therapy

Genetic variations may help predict breast cancer risk in women who receive preventive therapy

Findings provide basis for reinvigoration of research efforts in breast cancer prevention

Findings provide basis for reinvigoration of research efforts in breast cancer prevention

Web-based decision guide reduces uncertainty about breast cancer prevention options

Web-based decision guide reduces uncertainty about breast cancer prevention options